特立帕肽治疗后行后路矫形融合术治疗糖皮质激素性骨质疏松相关多发性椎体骨折:一例病例报告
本文报告一例24岁女性糖皮质激素性骨质疏松患者,在接受阿仑膦酸钠、维生素D和依降钙素治疗期间仍发生多发性椎体骨折。未行椎体成形术或球囊后凸成形术,先以特立帕肽改善骨质疏松,再对胸腰段后凸行后路矫形融合术;术后2年矫正位置维持,无新发骨折。作者认为该序贯策略可能获得更有利结局。
要点
- 糖皮质激素性骨质疏松患者椎体骨折术后再发骨折率高,手术治疗困难。
- 本例未早期行椎体成形术或球囊后凸成形术,先以特立帕肽改善骨质疏松。
- 随后行后路矫形融合术,术后2年矫正位置维持且无新发骨折。
核心结论
- 糖皮质激素性骨质疏松所致多发性椎体骨折尚无确立的治疗方法。
- 先以特立帕肽改善骨质疏松、再以矫形融合术治疗后凸,可能获得更有利的结局。
研究设计与样本
- 病例报告:1例24岁女性糖皮质激素性骨质疏松患者,在接受口服阿仑膦酸钠、维生素D和依降钙素注射治疗期间发生多发性椎体骨折。
主要发现
- 患者在接受口服阿仑膦酸钠、维生素D和依降钙素注射治疗期间仍发生继发性多发性椎体骨折,下腰痛逐渐加重。
- 早期未行椎体成形术或球囊后凸成形术,先以特立帕肽改善骨质疏松。
- 对残存胸腰段交界处后凸行后路矫形融合术,术后2年矫正位置维持且无新发骨折。
临床怎么用
- 作者认为,先以特立帕肽改善骨质疏松、再以矫形融合术治疗后凸,可能获得更有利的结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Surgical treatment of multiple vertebral fractures in patients with glucocorticoid-induced osteoporosis is difficult because of a high rate of secondary fracture postoperatively. A case is described in which initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion achieved a favorable outcome. INTRODUCTION: Secondary fracture frequently occurs after treatment of vertebral fracture with vertebroplasty and balloon kyphoplasty in patients with glucocorticoid-induced osteoporosis, but effective treatment of multiple vertebral fractures has rarely been reported. Thus, a treatment of kyphosis following multiple vertebral fractures associated with glucocorticoid-induced osteoporosis is required. METHODS: The patient was a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis who was under treatment with oral alendronate, vitamin D, and elcatonin injection. Secondary multiple vertebral fractures occurred despite these treatments and low back pain gradually aggravated. RESULTS: Vertebroplasty or balloon kyphoplasty was not performed in the early phase. Instead, treatment with teriparatide was used for initial improvement of osteoporosis. Kyphosis in the center of the residual thoracolumbar junction was then treated with posterior correction fusion. At 2 years after surgery, the corrected position has been maintained and no new fracture has occurred. CONCLUSION: There is no established method for treatment of multiple vertebral fractures caused by glucocorticoid-induced osteoporosis. Initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion may result in a more favorable outcome.
引用
- Uei H, Tokuhashi Y, Maseda M, et al. Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report. Osteoporos Int. 2018. PMID: 29476202. doi:10.1007/s00198-018-4425-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。